Interestingly, tumor cells positive for p-AMPK and GLUT1 were enriched at the interface of normoxic and hypoxic regions of the GPx2 KD tumor, where both metabolic modalities may be needed. This evidence concerns the gene SLC2A1 and neoplasm.